Scholarlink

<p>Palm date (<i>Phoenix dactylifera</i> L.) seeds are a widely discarded agricultural by-product that contain diverse bioactive phytochemicals. The present study investigated the anti-breast cancer potential of <i>P. dactylifera</i> seed extract through an integrated approach combining network pharmacology, molecular docking, molecular dynamics (MD) simulation, and in vitro experimental validation. HR-LCMS profiling of the ethanolic seed extract identified 57 compounds across both positive and negative ionization modes. Following ADME-based screening (OB greater than 30%, DL greater than or equal to 0.18), eight active compounds were retained for downstream analysis. Network pharmacology identified 214 shared targets between the active compounds and breast cancer-related genes, enriched across 156 KEGG pathways including PI3K-Akt, JAK-STAT, ErbB, and HIF-1 signaling. Protein–protein interaction analysis revealed STAT3, AKT1, and EGFR as the top hub targets. Molecular docking showed that tubulosine, oxolucidine B, and deoxytubulosine exhibited binding affinities ranging from − 7.1 to − 11.2 kcal/mol against the three hub targets. MD simulations over 100 ns confirmed the conformational stability of the oxolucidine B-AKT1, deoxytubulosine-EGFR, and oxolucidine B-STAT3 complexes, as assessed by RMSD, RMSF, Rg, hydrogen bond, and SASA analyses. In vitro MTT assay on MCF-7 cells yielded an IC<sub>50</sub> of 416.21 μg/mL, and the extract inhibited cell migration (approximately 30–40% wound closure vs. 85–90% in control at 44 h) and invasion (approximately 60% reduction in migrated cells) at the IC<sub>50</sub> concentration. These findings point to palm date seeds as a source of multi-target phytochemicals warranting further fractionation and mechanistic validation for breast cancer research.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Therapeutic potential of date seed (Phoenix dactylifera) powder against human breast cancer: integrated computational and experimental analyses

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月29日

查看全文
  • Salem Elkahoui,
  • Najla Haddaji,
  • Ahmed Eisa Mahmoud Ghoniem,
  • Riadh Badraoui,
  • Mejdi Snoussi

摘要

Palm date (Phoenix dactylifera L.) seeds are a widely discarded agricultural by-product that contain diverse bioactive phytochemicals. The present study investigated the anti-breast cancer potential of P. dactylifera seed extract through an integrated approach combining network pharmacology, molecular docking, molecular dynamics (MD) simulation, and in vitro experimental validation. HR-LCMS profiling of the ethanolic seed extract identified 57 compounds across both positive and negative ionization modes. Following ADME-based screening (OB greater than 30%, DL greater than or equal to 0.18), eight active compounds were retained for downstream analysis. Network pharmacology identified 214 shared targets between the active compounds and breast cancer-related genes, enriched across 156 KEGG pathways including PI3K-Akt, JAK-STAT, ErbB, and HIF-1 signaling. Protein–protein interaction analysis revealed STAT3, AKT1, and EGFR as the top hub targets. Molecular docking showed that tubulosine, oxolucidine B, and deoxytubulosine exhibited binding affinities ranging from − 7.1 to − 11.2 kcal/mol against the three hub targets. MD simulations over 100 ns confirmed the conformational stability of the oxolucidine B-AKT1, deoxytubulosine-EGFR, and oxolucidine B-STAT3 complexes, as assessed by RMSD, RMSF, Rg, hydrogen bond, and SASA analyses. In vitro MTT assay on MCF-7 cells yielded an IC50 of 416.21 μg/mL, and the extract inhibited cell migration (approximately 30–40% wound closure vs. 85–90% in control at 44 h) and invasion (approximately 60% reduction in migrated cells) at the IC50 concentration. These findings point to palm date seeds as a source of multi-target phytochemicals warranting further fractionation and mechanistic validation for breast cancer research.